Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liewei Wang

Showing results (171-180 of 277) with videos related to

Pageof 28
Sort By:
Pharmacogenetics and Genomics|December 4, 2010
Polymorphisms in genes coding for GRK2 and GRK5 and response differences in antihypertensive-treated patientsMaximilian T Lobmeyer, Liewei Wang, Issam Zineh, et al.
AJR. American Journal of Roentgenology|June 6, 2019
Comparison of <sup>99m</sup>Tc-Sestamibi Molecular Breast Imaging and Breast MRI in Patients With Invasive Breast Cancer Receiving Neoadjuvant ChemotherapyKatie N Hunt, Amy Lynn Conners, Matthew P Goetz, et al.
Prostate Cancer and Prostatic Diseases|June 3, 2018
Prognostic association of plasma cell-free DNA-based androgen receptor amplification and circulating tumor cells in pre-chemotherapy metastatic castration-resistant prostate cancer patientsManish Kohli, Jian Li, Meijun Du, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2011
Genetic variation predicting cisplatin cytotoxicity associated with overall survival in lung cancer patients receiving platinum-based chemotherapyXiang-Lin Tan, Ann M Moyer, Brooke L Fridley, et al.
Cancer Research|May 21, 2021
Quantitative Analysis of Tyrosine Phosphorylation from FFPE Tissues Reveals Patient-Specific Signaling NetworksIshwar N Kohale, Danielle M Burgenske, Ann C Mladek, et al.
Pharmacogenetics and Genomics|December 17, 2011
Gemcitabine metabolic pathway genetic polymorphisms and response in patients with non-small cell lung cancerLiang Li, Daniel J Schaid, Brooke L Fridley, et al.
Breast Cancer Research and Treatment|January 11, 2015
A polygenic risk score for breast cancer in women receiving tamoxifen or raloxifene on NSABP P-1 and P-2Celine M Vachon, Daniel J Schaid, James N Ingle, et al.
JCO Clinical Cancer Informatics|January 18, 2019
PANOPLY: Omics-Guided Drug Prioritization Method Tailored to an Individual PatientKrishna R Kalari, Jason P Sinnwell, Kevin J Thompson, et al.
Journal of Clinical Psychopharmacology|April 7, 2025
Antidepressant non-refill as a Proxy Measure for Medication Acceptability in Electronic Health RecordsJorge A Sanchez-Ruiz, Melissa Solares-Bravo, Gregory D Jenkins, et al.
Frontiers in Pharmacology|October 20, 2022
Network science approach elucidates integrative genomic-metabolomic signature of antidepressant response and lifetime history of attempted suicide in adults with major depressive disorderCaroline W Grant, Angelina R Wilton, Rima Kaddurah-Daouk, et al.
Pageof 28

Showing results (171-180 of 277) with videos related to

Sort By:
Pageof 28
Pharmacogenetics and Genomics|December 4, 2010
Polymorphisms in genes coding for GRK2 and GRK5 and response differences in antihypertensive-treated patientsMaximilian T Lobmeyer, Liewei Wang, Issam Zineh, et al.
AJR. American Journal of Roentgenology|June 6, 2019
Comparison of <sup>99m</sup>Tc-Sestamibi Molecular Breast Imaging and Breast MRI in Patients With Invasive Breast Cancer Receiving Neoadjuvant ChemotherapyKatie N Hunt, Amy Lynn Conners, Matthew P Goetz, et al.
Prostate Cancer and Prostatic Diseases|June 3, 2018
Prognostic association of plasma cell-free DNA-based androgen receptor amplification and circulating tumor cells in pre-chemotherapy metastatic castration-resistant prostate cancer patientsManish Kohli, Jian Li, Meijun Du, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2011
Genetic variation predicting cisplatin cytotoxicity associated with overall survival in lung cancer patients receiving platinum-based chemotherapyXiang-Lin Tan, Ann M Moyer, Brooke L Fridley, et al.
Cancer Research|May 21, 2021
Quantitative Analysis of Tyrosine Phosphorylation from FFPE Tissues Reveals Patient-Specific Signaling NetworksIshwar N Kohale, Danielle M Burgenske, Ann C Mladek, et al.
Pharmacogenetics and Genomics|December 17, 2011
Gemcitabine metabolic pathway genetic polymorphisms and response in patients with non-small cell lung cancerLiang Li, Daniel J Schaid, Brooke L Fridley, et al.
Breast Cancer Research and Treatment|January 11, 2015
A polygenic risk score for breast cancer in women receiving tamoxifen or raloxifene on NSABP P-1 and P-2Celine M Vachon, Daniel J Schaid, James N Ingle, et al.
JCO Clinical Cancer Informatics|January 18, 2019
PANOPLY: Omics-Guided Drug Prioritization Method Tailored to an Individual PatientKrishna R Kalari, Jason P Sinnwell, Kevin J Thompson, et al.
Journal of Clinical Psychopharmacology|April 7, 2025
Antidepressant non-refill as a Proxy Measure for Medication Acceptability in Electronic Health RecordsJorge A Sanchez-Ruiz, Melissa Solares-Bravo, Gregory D Jenkins, et al.
Frontiers in Pharmacology|October 20, 2022
Network science approach elucidates integrative genomic-metabolomic signature of antidepressant response and lifetime history of attempted suicide in adults with major depressive disorderCaroline W Grant, Angelina R Wilton, Rima Kaddurah-Daouk, et al.
Pageof 28